{{Drugbox
|verifiedrevid = 459442789
|IUPAC_name = (''RS'')-4-(2-{{(}}[4-(4-hydroxyphenyl)butan-2-yl]amino{{)}}ethyl)benzene-1,2-diol
|image = Dobutamine.svg
|width = 250
|chirality = [[外消旋混合物|外消旋混合物]]

<!--Clinical data-->
|tradename = Dobutrex
|Drugs.com = {{drugs.com|monograph|dobutamine-hydrochloride}}
|MedlinePlus = a682861
|pregnancy_category = B
|legal_status = Rx-only  
|routes_of_administration = 靜脈注射

<!--Pharmacokinetic data-->
|bioavailability =  
|protein_bound =  
|metabolism =  
|elimination_half-life = 2 分鐘

<!--Identifiers-->
|CAS_number_Ref = {{cascite|correct|??}}
|CAS_number = 34368-04-2
|ATC_prefix = C01
|ATC_suffix = CA07
|ATC_supplemental =  
|PubChem = 36811
|IUPHAR_ligand = 535
|DrugBank_Ref = {{drugbankcite|correct|drugbank}}
|DrugBank = DB00841
|ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
|ChemSpiderID = 33786
|UNII_Ref = {{fdacite|correct|FDA}}
|UNII = 0WR771DJXV
|KEGG_Ref = {{keggcite|correct|kegg}}
|KEGG = D03879
|ChEBI_Ref = {{ebicite|correct|EBI}}
|ChEBI = 4670
|ChEMBL_Ref = {{ebicite|correct|EBI}}
|ChEMBL = 926

<!--Chemical data-->
|C=18 | H=23 | N=1 | O=3
|molecular_weight = 301.38 g/mol
|smiles = Oc1ccc(cc1O)CCNC(C)CCc2ccc(O)cc2
|StdInChI_Ref = {{stdinchicite|correct|chemspider}}
|StdInChI = 1S/C18H23NO3/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15/h4-9,12-13,19-22H,2-3,10-11H2,1H3
|StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
|StdInChIKey = JRWZLRBJNMZMFE-UHFFFAOYSA-N
|synonyms = Dobutrex, Inotrex
}}

'''多保他命'''（{{lang|en|Dobutamine}}）是一種[[擬交感神經性|擬交感神經性]][[药物|药物]]，用於[[心臟衰竭|心臟衰竭]]及[[心因性休克|心因性休克]]的治療。本品屬於[[交感神经|交感神经]]的[[肾上腺素受体|β<sub>1</sub>受體致活劑]]。多保他命最初於1970年代由任職於[[礼来公司|礼来公司]]的 Ronald Tuttle 和 Jack Mills 博士所開發，為{{tsl|en|isoprenaline||isoprenaline}}的{{tsl|en|analog (chemistry)|結構相似物|相似物}}<ref>{{cite journal |vauthors=Tuttle RR, Mills J |title=Dobutamine: development of a new catecholamine to selectively increase cardiac contractility |journal=Circ Res |volume=36 |issue=1 |pages=185–96 |date=January 1975 |pmid=234805 |url=http://circres.ahajournals.org/cgi/reprint/36/1/185 |doi=10.1161/01.RES.36.1.185 |access-date=2016-10-18 |archive-date=2021-08-28 |archive-url=https://web.archive.org/web/20210828064321/https://www.ahajournals.org/doi/abs/10.1161/01.res.36.1.185 |dead-url=no }}</ref>。

==臨床用途==
多保他命屬於正性{{tsl|en|inotrope|肌力}}藥物，可用於治療急性[[心臟衰竭|心臟衰竭]]，例如[[心脏外科|手術期間]]或[[敗血性休克|敗血性]]及心因性休克的心衰竭<ref name="rang">{{cite book |vauthors=Rang HP, Dale MM, Ritter JM, Flower RJ |title=Rang and Dale's Pharmacology}}</ref>。

==參見==
*[[萊克多巴胺|萊克多巴胺]]（多保他命的[[结构异构|結構異構物]]）
*{{tsl|en|Arbutamine||Arbutamine}}

==參考文獻==
{{reflist}}

{{Adrenergic agonists}}
{{Cardiac stimulants excluding cardiac glycosides}}

{{tsl|en|Category:Beta1-adrenergic agonists||Category:Beta1-adrenergic agonists}}
[[Category:变力剂|Category:变力剂]]